Polyhexamethylene biguanide treatment for Acanthamoeba keratitis.
Sullivan
L
L
D000048:Acanthamoeba / Q000187:drug effects / Q000302:isolation & purification; D015823:Acanthamoeba Keratitis / Q000188:drug therapy* / Q000469:parasitology; D000818:Animals; D000900:Anti-Bacterial Agents; D001645:Biguanides / Q000008:administration & dosage / Q000627:therapeutic use*; D004202:Disinfectants / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D009883:Ophthalmic Solutions; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D001645:Biguanides; D004202:Disinfectants; D009883:Ophthalmic Solutions; C031233:polihexanide